Factors associated with human herpesvirus type 8 infection in an injecting drug user cohort

Sexually Transmitted Diseases

Volumn 30, Issue 3, 2003, Pages 199-204

  Bernstein, Kyle T ^a   Jacobson, Lisa P ^a   Jenkins, Frank J ^b   Vlahov, David ^a   Armenian, Haroutune K ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONDYLOMA; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HERPES VIRUS INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; SEXUAL BEHAVIOR; BLOOD; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MULTICENTER STUDY; STATISTICAL MODEL; SUBSTANCE ABUSE; UNITED STATES; VIROLOGY;

ADULT; BALTIMORE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LOGISTIC MODELS; MALE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0037337180     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200303000-00004     Document Type: Article

References (50)

1. Armenian HK, Hoover DR, Rubb S, et al. Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol 1993; 138:256-265.
2. Biggar RJ, Rosenberg PS, Cote T. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group. Int J Cancer 1996; 68: 754-758.
3. Franceschi S, Serraino D. Kaposi's sarcoma and KSHV. Lancet 1995; 346:1360-1361.
4. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993; 138:266-278.
5. Jacobson LP, Munoz A, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group. J AIDS 1990; 3(suppl 1):S24-S31.
6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1994; 6:1-27.
7. Haverkos HW, Drotman DP. Prevalence of Kaposi's sarcoma among patients with AIDS. N Engl J Med 1985; 312:1518.
8. Haverkos HW, Friedman-Kien AE, Drotman DP, Morgan WM. The changing incidence of Kaposi's sarcoma among patients with AIDS. J Am Acad Dermatol 1990; 22:1250-1253.
9. Jaffe HW. AIDS: epidemiologic features. J Am Acad Dermatol 1990; 22:1167-1171.
10. Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1987; 1:175-182.
11. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
12. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268:582-583.
13. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345:1043-1044.
14. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med 1996; 156:202-204.
15. Decker LL, Shankar P, Khan G, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996; 184:283-288.
16. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-928.
17. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335:233-241.
18. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345:759-761.
19. Kennedy MM, Lucas SB, Russell-Jones R, et al. HHV8 and female Kaposi's sarcoma. J Pathol 1997; 183:447-452.
20. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348:858-861.
21. Melbye M, Cook PM, Hjalgrim H, et al. Risk factors for Kaposi'ssarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998; 77:543-548.
22. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332:1181-1185.
23. Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcomaassociated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10:175-180.
24. Parry JP, Moore PS. Corrected prevalence of Kaposi's sarcoma (KS)associated herpesvirus infection prior to onset of KS. AIDS 1997; 11:127-128.
25. Viviano E, Vitale F, Ajello F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV- positive and negative individuals in Sicily. AIDS 1997; 11:607-612.
26. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799-802.
27. Goudsmit J, Renwick N, Dukers NH, et al. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A 2000; 97:4838-4843.
28. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-954.
29. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P. High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbiol 1998; 36:1784-1786.
30. Verbeek W, Frankel M, Miles S, Said J, Koeffler HP. Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up. Am J Clin Pathol 1998; 109:778-783.
31. Bestetti G, Renon G, Mauclere P, et al. High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 1998; 12:541-543.
32. Cannon MJ, Dollard SC, Smith DK, et al. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 2001; 344:637-643.
33. Goedert JJ, Kedes DH, Ganem D. Antibodies to human herpesvirus 8 in women and infants born in Haiti and the USA. Lancet 1997; 349:1368.
34. Greenblatt RM, Jacobson LP, Levine AM, et al. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis 2001; 183:1130-1134.
35. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and highrisk HIV-seronegative women. JAMA 1997; 277:478-481.
36. Sosa C, Klaskala W, Chandran B, et al. Human herpesvirus 8 as a potential sexually transmitted agent in Honduras. J Infect Dis 1998; 178:547-551.
37. Whitby D, Smith NA, Matthews S, et al. Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999; 179:234-236.
38. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348:1133-1138.
39. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109:75-100.
40. Jacobson LP, Jenkins FJ, Springer G, et al. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000; 181:1940-1949.
41. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998; 352:1510-1514.
42. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998; 77:361-365.
43. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335:123-128.
44. Greenblatt RM. Kaposi's sarcoma and human herpesvirus-8. Infect Dis Clin North Am 1998; 12:63-82.
45. Olweny CLM. Epidemiology and clinical features of Kaposi's sarcoma in tropical Africa. In: Friedman-Kien AE. Lauberstein JL. The Epidemic of Kaposi's Sarcoma and Opportunistic Infections. Masson Publishing, 1984:35-40.
46. Blower SM, Boe C. Sex acts, sex partners, and sex budgets: implications for risk factor analysis and estimation of HIV transmission probabilities. J AIDS 1993; 6:1347-1352.
47. Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994; 84:382-387.
48. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375:64-68.
49. Rabkin CS, Chibwe G, Muyunda K, Musaba E. Kaposi's sarcoma in pregnant women. Nature 1995; 377:21.
50. Tedeschi R, Caggiari L, Silins I, et al. Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women. Int J Cancer 2000; 87:232-235.